Florida Cancer Specialists & Research Institute Welcomes Dr. Michael T. Scott

  • November 1, 2017

New Radiation Oncologist Joins in Hillsborough County 

Tampa, FL – November 1, 2017. . . Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, is pleased to announce that radiation oncologist Michael T. Scott, MD, MBAhas joined the statewide practice and is seeing patients at the Tampa Cancer Center of Florida Cancer Specialists, located at 3402 Dr. M L King Blvd West, Tampa, FL 33607.
FCS CEO Brad Prechtl said, “We are delighted to welcome Dr. Scott to Florida Cancer Specialists. He has an excellent reputation in Florida and will offer added convenience for our patients in Hillsborough County. We are very pleased to have him join the FCS family.”
Dr. William Harwin, Founder and President of FCS, added, “Dr. Scott comes to us with outstanding credentials and a keen interest in clinical research.  As a highly dedicated and respected radiation oncologist, Dr. Scott will be a great addition to our network in the Tampa communities.”
Dr. Michael T. Scott received his B.S.E. degree in Biomedical Engineering at Duke University located in Durham, NC, and attended medical and graduate school at the University of Florida (UF), Gainesville, FL. In 2011, Dr. Scott graduated from UF with his Medical degree and Masters in Business Administration. Subsequently, he relocated to Miami, Florida and completed his Residency at the University of Miami (UM) Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital and was awarded Chief Resident. Dr. Scott is a board-certified radiation oncologist by the American Board of Radiology (ABR) and has been published in several peer reviewed journals. Currently, he is a member of American Society of Clinical Oncology (ASCO), Florida Society of Clinical Oncology (FLASCO), American College of Radiation (ACR), Florida Radiological Society (FRS) and the American Society of Therapeutic Radiation Oncology (ASTRO). In his leisure time, he enjoys playing tennis, golf and traveling. Also, Dr. Scott is fluent in both English and Spanish to better serve the Hillsborough County community. 
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 160 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state’s leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast from Jacksonville/Fleming Island to Palm Beach County.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer – SGlenn@FLCancer.com
770.365.6168

ChappellRoberts
Chris Wilkerson – cwilkerson@chappellroberts.com
813.857.7051

Ganick Communications, Inc.
Elaine Ganick – elaine@ganick.com
615.377.7877

© 2021 FLASCO | Premium Website Design by The HDG